Abstract: Brain-Computer Interfaces (BCIs) enable control by decoding neural activity, offering autonomy to individuals with paralysis. This study presents an Electroencephalogram (EEG)-based ...
Michigan Medicine opened the Brain-Computer Interface Clinic — one of the first of its kind in the nation — on Dec. 16, 2025 to provide neurological assessments for patients with speech and motor ...
OpenAI has become the lead investor in Merge Labs, a new brain-computer interface research lab co-founded by Sam Altman that just raised around $250 million USD in seed funding Merge Labs is ...
OpenAI (OPENAI) announced on Thursday that it has invested in brain computer interface startup Merge Labs, which includes OpenAI CEO Sam Altman as an investor. Brain computer interfaces, or BCIs, ...
Tiny lab-grown brains are offering an unprecedented look at how schizophrenia and bipolar disorder disrupt neural activity. Researchers found distinct electrical firing patterns that could identify ...
OpenAI CEO Sam Altman’s new brain-computer interface startup, Merge Labs, is being spun out of the Los Angeles–based nonprofit Forest Neurotech, according to a source with direct knowledge of the ...
eSpeaks’ Corey Noles talks with Rob Israch, President of Tipalti, about what it means to lead with Global-First Finance and how companies can build scalable, compliant operations in an increasingly ...
Succinylation, a nexus between metabolism and epigenetic regulation, is a central factor in the onset and progression of neurodegenerative diseases (NDDs). Research has demonstrated a close ...
After achieving early breakthroughs in materials development, in vitro nanoparticle stimulation and signal reading, Subsense secures additional $10 million to accelerate product development and ...
Accurately and efficiently capturing large-scale neural signals is a core objective of next-generation brain-machine interface (BMI) technology, as well as a critical breakthrough direction in ...
US brain-computer-interface startup Paradromics is quickly establishing itself as a major player in the neural-device space, with the Food and Drug Administration (FDA) green-lighting a human trial to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results